NICE In Brief
This article was originally published in The Gray Sheet
Executive Summary
U.K. institute says DySIS Medical's digital video colposcope is a clinically effective and cost-effective option for detecting cervical cancer. But it calls for more research on stenting to prevent stroke. More NICE briefs.
You may also be interested in...
People Briefs: FDA Turnover; Appointments At Boston Scientific, Dysis Medical
FDA Chief Scientist Jesse Goodman leaves agency. New FDA deputy commissioner for global regulatory operations and policy appointed. Boston Scientific names new chief medical officer. More people briefs.
International News In Brief
St. Jude Brio pulled from overseas markets. Another U.K. metal-on-metal hip alert. More international device news.
Intracranial Stenting Doesn’t Make The Cut In NIH Study
Intracranial stenting should not be a first-line treatment in most patients with narrowed brain arteries and a recent neurological event, researchers concluded in a recent study. But the data should not be viewed as a nail in the coffin to future development of intracranial stents, investigators stressed.